Please assess the completion status of the following clinical trial:

Trial Title: Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Subjects are enrolled in this study if they:~* Met entrance criteria and were enrolled and imaged in trial 18F-AV-45-A07 (NCT00857415)~* Gave informed consent for the 18F-AV-45-A07 (NCT00857415) study procedures and brain donation consistent with the legal requirements of the State in which they are enrolled and the State in which they die~* Consent to participate in the 18F-AV-45-A16 (NCT01447719) extension protocol, if required by the IRB~* Reconfirm their consent to a research brain autopsy, if required by the IRB.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).